Navigation Links
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
Date:5/12/2008

Live Audio Webcast Thursday, May 22, 2008

SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Neurocrine Biosciences will present at the Citi Investment Research Global Health Care Conference at the Hilton New York. The live presentation takes place Thursday, May 22, 2008 at 3:00 p.m. Eastern Time (ET) /12:00 p.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
3. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
4. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
5. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
7. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
8. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Neurocrine Announces Work Force Restructuring
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , The New York investmen... Ltd (ASX:NEU) has agreed an AU$6.7 mil convertibl... investor. The private placement was arranged by K...nd advisor. , New York (P...k investment bank KTA Capital, LLC ("KTA Capi...
(Date:11/24/2009)... , , ST. LOUIS, Nov. 24 /PRNewswire-Fi...AL ) will be presenting at the NASDAQ OMX conferen...on, 7:45 AM US/CST. Interested parties may listen ...le at http://inve s tor.sig m a a ldrich.c...ss this file. ,, About Sigma-Aldrich: Sig...
(Date:11/24/2009)... , , SAN MATEO, Calif., Nov. 24 /PRNe...X ), a biopharmaceutical company focused on develo...rapies, announced today that Anthony DiTonno, Pres... present at the 21st Annual Piper Jaffray Health C...he New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)... , , , Primary efficacy endpoint has ...ecurrent endometrial cancer, , QUEBEC CITY, N...nc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a ...ine therapy and oncology, today announced positive...ted cytotoxic peptide conjugate, AEZS-108 (formerl...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...K, May 7 /PRNewswire-FirstCall/ -- Delcath Syst...gy company testing its proprietary Percutaneous He... of cancers of the liver, announced today that Eri...a Center and a Principal Investigator of Delcath,s...ngress on Melanoma, to be held in Vienna, Austria,...
...MA, Italy, May 7 The Parma Group has reacquired t...s laying the groundwork to,acquire control of the ...ll,be setting up its twenty-third associated compa...This presence in the USA will prepare the way for,...espiratory illnesses. , The Chiesi Group has c...
... Calif., May 7 BioMarin Pharmaceutical Inc. (Nasd...ce President of Business and Corporate Development... Baird Growth Stock Conference in Chicago on Thurs...ted parties may access a live audio webcast of the...ioMarin website, www.BMRN.com . A replay of th...
Other Biology Technology:Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma 2Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma 3The Chiesi Group Lands in the United States 2The Chiesi Group Lands in the United States 3BioMarin to Present at the Baird Growth Stock Conference 2
(Date:11/26/2009)...hicillin-resistant Staphylococcus Aureus ) and ot...n as low-temperature plasma prototype devices have...ailing bactericidal cocktails. , Two prototype d...nfection of healthy skin (e.g. hands and feet) in ...e a lethal threat; and another to shoot bacteria-k...
(Date:11/25/2009)...ber 11, firefighters, police officers and ambulanc...World Trade Center complex. They battled to save p...r survivors, tackled fires and evacuated as many p...estimated 17,000 people. And making their jobs eve...rightened workers and their relatives jammed mobil...
(Date:11/25/2009)...State University assistant professors recently rec... (NSF) to continue research beneficial to understa...,000. , Christopher Blackwood, assistant profess...warded grants to support two separate research pro...itter Decomposer Communities and Functions from th...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 1Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 4Oxygen + MRI might help determine cancer therapy success researchers find 47725 1Oxygen + MRI might help determine cancer therapy success researchers find 47725 2Dr Erika says Newsweeks Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47723 1Dr Erika says Newsweeks Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47723 2
...any researchers have believed women choose partner...ng, a new study from The University of Texas at Au...by their own attractiveness. , David Buss, psycho...he findings in Attractive Women Want it All: Good ... and Emotional Commitment in this months Evolution...
... neuron disease is a rare, devastating illness in ...les gradually deteriorate. One form of it, Lou Geh...), is familiar to the public in the lives of scien...om Mitch Alboms Tuesdays with Morrie was written. ...iguring out why these people develop the disease, ...
... Purdue University researchers have identified sev...the Midwest like southern Indiana and are resistan...ite with a recently confirmed presence in that par...esistance in soybeans to one nematode parasite doe...ther nematode species, said Andreas Westphal, assi...
Other Biology News:Do attractive women want it all? 2Motor neuron disease and toxic substances: Possible link? 2Motor neuron disease and toxic substances: Possible link? 3Soybean varieties viable in southern Indiana, resistant to root-knot nematode 2Soybean varieties viable in southern Indiana, resistant to root-knot nematode 3
Mouse Anti-Human KAI 1 Monoclonal Antibody, Unconjugated, Clone G-2 from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited
Rat Anti-Mouse OSMR Monoclonal Antibody, Unconjugated, Clone 30-1 from MBL International
...gned for use with the ProQuest Two-Hybrid System (...letions in the endogenous GAL4 and GAL80 genes for...n also has leu2 and trp1 mutations for selection o...three GAL4 inducible reporter genes, providing fou...
Biology Products: